Skip to main content

Table1 Anthropometric and laboratory characteristics of the study population

From: The circulating levels of CTRP1 and CTRP5 are associated with obesity indices and carotid intima-media thickness (cIMT) value in patients with type 2 diabetes: a preliminary study

Characteristics

Controls

(n = 42)

T2DM

(n = 42)

P value

Age, years

51 (48–57.25)

55 (46.50–59.25)

0.622

Waist, cm

99.5 ± 10.2

104. 5 ± 11.3

0.039

Hips, cm

102.4 ± 6.4

103.8 ± 7.2

0.363

WHR, -

0.97 ± 0.05

1.004 ± 0.06

0.012

Height, cm

169.5 ± 5.7

168.1 ± 5.7

0.281

Weight, kg

78.0 ± 11.9

81.3 ± 12.1

0.212

BMI, kg/m2

27.13 ± 3.72

28.78 ± 4.33

0.064

FBG, mg/dL

93.50 (87.01–99.17)

146 (123.45–183.07)

0.000

Insulin, μU/mL

8 (3.50–10.10)

7.10 (4.35–9.55)

0.906

HOMA-IR, -

1.79 (0.83–2.43)

2.61 (1.58–3.77)

0.009

Triglycerides, mg/dL

129.10 (93.85–160.30)

142.30 (108.28–184.40)

0.214

Cholesterol, mg/dL

196.50 (167.85–213.90)

202.60 (167.88–221.45)

0.545

HDL, mg/dl

50.10 (44.45–55.90)

55.90 (44.23–64.25)

0.225

LDL, mg/dL

113.71 ± 32.23

115.73 ± 37.56

0.796

LDL to HDL, -

2.26 ± 0.67

2.152 ± 0.63

0.451

Urea, mg/dL

30.46 ± 7.58

32.20 ± 6.55

0.272

Creatinine, mg/dL

1.27 ± 0.18

1.21 ± 0.18

0.164

AST, U/L

18.70 (16.20–23.93)

20.20 (15.98–26.15)

0.679

ALT, U/L

20.50 (14.30–29.65)

22.80 (14.98–40.20)

0.255

ALP, U/L

227 (196.50–263)

220 (185.75–285)

0.810

γ-GT, U/L

24.33 (19.58–32.10)

28.34 (21.69–43.91)

0.045

SBP, mmHg

122 (113.75–140)

132 (120–150)

0.081

DBP, mmHg

80(70–90)

80 (74.25–90)

0.876

Visceral Fat, %

60.76 ± 22.35

66.26 ± 21.90

0.258

WBC, × 109/L

5.40 (1.9)

6.70 (2)

0.029

cIMT, mm

0.79 ± 0.10

0.83 ± 0.12

0.086

VAI

1.60 (1.11–2.05)

1.67 (1.25–2.27)

0.577

  1. Continuous variables with normal distribution were described as mean ± SD and with non-normal distribution were described as Median (IQR)
  2. T2D type 2 diabetes, WC waist circumference, WHRwaist-to-hip ratio, BMI body mass index, FBG fasting blood glucose, HOMA-IR homeostasis model assessment of insulin resistance, TG triglycerides, TC total cholesterol, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, ALT alanine aminotransferase, AST aspartate aminotransferase, ɤ-GT gamma-glutamyl transferase, ALP alkaline phosphatase, SBP systolic blood pressure, DBP diastolic blood pressure, VAI visceral adiposity index, WBC white blood cells, cIMT carotid intima-media thickness